Author Topic: Tecfidera, Gilenya, Ocrevus losing ground to more recent MS therapies  (Read 46 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9821
  • MS diagnosed 1980
  • Location: Pacific Northwest

From Multiple Sclerosis News Today (April 7, 2021)--"Tecfidera, Gilenya, Ocrevus Losing Favor as Switch Therapies in US, Spherix Finds":


https://multiplesclerosisnewstoday.com/news-posts/2021/04/07/tecfidera-gilenya-ocrevus-losing-ground-ms-dmt-switches-us-spherix-survey/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
160 Views
Last post June 08, 2018, 09:02:03 pm
by agate
0 Replies
141 Views
Last post June 08, 2018, 09:06:06 pm
by agate
0 Replies
54 Views
Last post February 11, 2020, 08:05:28 pm
by agate
0 Replies
37 Views
Last post July 18, 2021, 09:27:34 pm
by agate
0 Replies
33 Views
Last post November 20, 2021, 09:43:09 pm
by agate